Tian Lan

1.0k total citations
21 papers, 728 citations indexed

About

Tian Lan is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Tian Lan has authored 21 papers receiving a total of 728 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Cancer Research and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Tian Lan's work include Cancer-related molecular mechanisms research (8 papers), Circular RNAs in diseases (5 papers) and MicroRNA in disease regulation (4 papers). Tian Lan is often cited by papers focused on Cancer-related molecular mechanisms research (8 papers), Circular RNAs in diseases (5 papers) and MicroRNA in disease regulation (4 papers). Tian Lan collaborates with scholars based in China, Germany and United States. Tian Lan's co-authors include Yufeng Yuan, Lei Chang, Long Wu, Long Wu, Weijie Ma, Xi Chen, Cuicui Li, Zhisu Liu, Quanyan Liu and Xinghuan Wang and has published in prestigious journals such as Cancer Research, Gut and Scientific Reports.

In The Last Decade

Tian Lan

21 papers receiving 717 citations

Peers

Tian Lan
Qiying Chen China
Guannan Tang China
Bei‐Ge Jiang China
Chencheng Xie United States
Qigu Yao China
Bijun Qiu China
Jinjin Qi China
Guangyuan Song China
Qiying Chen China
Tian Lan
Citations per year, relative to Tian Lan Tian Lan (= 1×) peers Qiying Chen

Countries citing papers authored by Tian Lan

Since Specialization
Citations

This map shows the geographic impact of Tian Lan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tian Lan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tian Lan more than expected).

Fields of papers citing papers by Tian Lan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tian Lan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tian Lan. The network helps show where Tian Lan may publish in the future.

Co-authorship network of co-authors of Tian Lan

This figure shows the co-authorship network connecting the top 25 collaborators of Tian Lan. A scholar is included among the top collaborators of Tian Lan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tian Lan. Tian Lan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Hanyang, Yin Guo, Tian Lan, et al.. (2025). Reactive cholangiocyte-derived ORM2 drives a pathogenic modulation of the injured biliary niche through macrophage reprogramming. Gut. 74(10). 1694–1710. 6 indexed citations
2.
Gao, Jinhang, Tian Lan, Enis Kostallari, et al.. (2024). Angiocrine signaling in sinusoidal homeostasis and liver diseases. Journal of Hepatology. 81(3). 543–561. 32 indexed citations
3.
4.
Li, Yuejin, et al.. (2023). Bioinformatics-based identification of lipid- and immune-related biomarkers in abdominal aortic aneurysms. Heliyon. 9(2). e13622–e13622. 4 indexed citations
5.
Xu, Chengshi, Xiaochong Li, Chao Yang, et al.. (2023). Telmisartan inhibits microglia-induced neurotoxic A1 astrocyte conversion via PPARγ-mediated NF-κB/p65 degradation. International Immunopharmacology. 123. 110761–110761. 12 indexed citations
6.
Yang, Chao, Tian Lan, Yi Wang, et al.. (2022). Cumulative Scoring Systems and Nomograms for Predicating Survival in Patients With Glioblastomas: A Study Based on Peripheral Inflammatory Markers. Frontiers in Oncology. 12. 716295–716295. 12 indexed citations
7.
Lv, Yinghao, Zhen Wang, Tian Lan, et al.. (2022). FLASH radiotherapy: A promising new method for radiotherapy (Review). Oncology Letters. 24(6). 419–419. 17 indexed citations
8.
Wang, Xinghuan, et al.. (2020). Carmustine as a Supplementary Therapeutic Option for Glioblastoma: A Systematic Review and Meta-Analysis. Frontiers in Neurology. 11. 1036–1036. 55 indexed citations
9.
Lan, Tian & Hong Wu. (2020). Abstract 2932: CD59 facilitates tumor progression through activating TGF-β/Smad signaling pathway in hepatocellular carcinoma. Cancer Research. 80(16_Supplement). 2932–2932. 1 indexed citations
10.
Chen, Xi, et al.. (2018). The Abnormal Expression of MicroRNA-542-3p in Hepatocellular Carcinoma and Its Clinical Significance. Disease Markers. 2018. 1–9. 10 indexed citations
11.
Lan, Tian, et al.. (2017). Long non-coding RNA small nucleolar RNA host gene 12 (SNHG12) promotes tumorigenesis and metastasis by targeting miR-199a/b-5p in hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research. 36(1). 11–11. 138 indexed citations
12.
Lan, Tian, et al.. (2017). Prognostic role of long noncoding RNA ZFAS1 in cancer patients: a systematic review and meta-analysis. Oncotarget. 8(59). 100490–100498. 12 indexed citations
13.
Ma, Weijie, Xi Chen, Lu Ding, et al.. (2017). The prognostic value of long noncoding RNAs in prostate cancer: a systematic review and meta-analysis. Oncotarget. 8(34). 57755–57765. 18 indexed citations
14.
Lan, Tian, Yan Xia, Zhuo Li, et al.. (2017). Long non-coding RNA PVT1 serves as a competing endogenous RNA for miR-186-5p to promote the tumorigenesis and metastasis of hepatocellular carcinoma. Tumor Biology. 39(6). 3726132133–3726132133. 53 indexed citations
15.
Zhou, Fuxiang, Tian Lan, Hui Xu, et al.. (2016). Optimal postoperative nutrition support for patients with gastrointestinal malignancy: A systematic review and meta-analysis. Clinical Nutrition. 36(3). 710–721. 36 indexed citations
16.
Lan, Tian, Lei Chang, Long Wu, & Yufeng Yuan. (2016). Downregulation of ZEB2-AS1 decreased tumor growth and metastasis in hepatocellular carcinoma. Molecular Medicine Reports. 14(5). 4606–4612. 58 indexed citations
17.
Lan, Tian, et al.. (2016). Comparative Efficacy of Interventional Therapies for Early-stage Hepatocellular Carcinoma. Medicine. 95(15). e3185–e3185. 33 indexed citations
18.
Chang, Lei, Cuicui Li, Tian Lan, et al.. (2015). Decreased expression of long non-coding RNA GAS5 indicates a poor prognosis and promotes cell proliferation and invasion in hepatocellular carcinoma by regulating vimentin. Molecular Medicine Reports. 13(2). 1541–1550. 107 indexed citations
19.
Chen, Jie, Tian Lan, Weimin Zhang, et al.. (2015). Dasatinib enhances cisplatin sensitivity in human esophageal squamous cell carcinoma (ESCC) cells via suppression of PI3K/AKT and Stat3 pathways. Archives of Biochemistry and Biophysics. 575. 38–45. 36 indexed citations
20.
Chang, Lei, Tian Lan, Long Wu, et al.. (2015). The association between three IL-6 polymorphisms and HBV-related liver diseases: a meta-analysis.. PubMed. 8(10). 17036–45. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qiying Chen Breakdown of academic impact, for papers by Guannan Tang Breakdown of academic impact, for papers by Bei‐Ge Jiang Breakdown of academic impact, for papers by Chencheng Xie Breakdown of academic impact, for papers by Qigu Yao Breakdown of academic impact, for papers by Bijun Qiu Breakdown of academic impact, for papers by Jinjin Qi Breakdown of academic impact, for papers by Guangyuan Song
Rankless by CCL
2026